Home » Topics » Deals and M&A » Collaboration

Collaboration
RSS

BIND Biosciences and Amgen to develop a kinase inhibitor nanomedicine

Jan. 11, 2013

Adimab expands collaborations with Merck & Co. and Lilly

Jan. 11, 2013

Research alliance expands miRNA targets

Jan. 11, 2013

Chugai and Debiopharm enter license agreement for anticancer agent

Jan. 10, 2013

Ariad and U.K.'s NCRI to collaborate on phase III ponatinib trial

Jan. 9, 2013

Labrys Biologics acquires antibody for chronic migraine from Pfizer

Jan. 8, 2013

Philogen enters into worldwide licensing agreement with Pfizer for Dekavil

Jan. 7, 2013

Kyowa Hakko Kirin advances second oncology candidate under agreement with Dicerna

Jan. 7, 2013

Repligen and Pfizer sign worldwide licensing agreement for spinal muscular atrophy

Jan. 4, 2013

PharmaEngine and BeBetter enter oncology collaboration

Jan. 4, 2013

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 15, 2026.
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...